The Resurgence of the Athlete Biological Passport & Concerns Over Its Use in Professional Cycling
The recent case involving WorldTour rider Gotzonia Lascano marks a important moment in the fight against doping in professional cycling. It represents the highest-profile challenge under the Athlete Biological Passport (ABP) program in what appears too be a renewed effort by the union Cycliste Internationale (UCI) to identify and penalize potential cheaters.
Understanding the Athlete Biological Passport
Launched by the World Anti-Doping Agency (WADA) in 2008, the ABP fundamentally shifted the approach to anti-doping. Instead of solely focusing on detecting specific banned substances, it tracks an athlete’s biological markers over time.
Here’s how it works:
* The ABP establishes a baseline profile of each rider’s blood and steroid levels.
* It then flags any significant deviations from this established profile.
* these fluctuations can indicate the use of performance-enhancing drugs like EPO, blood transfusions, or other prohibited manipulations.
Initially, the UCI quickly adopted the program and began issuing sanctions. however, early cases faced legal challenges, with the Court of Arbitration for Sport (CAS) ultimately upholding the validity of the ABP.
While a valuable tool, the biological passport isn’t without limitations. Unlike a traditional anti-doping violation – which relies on a clear positive test for a banned substance – the ABP relies on the interpretation of a three-person expert panel.This subjective element can lead to complex legal battles.
Historically, the UCI has also leveraged ABP data to target riders exhibiting suspicious profiles, often leading to subsequent positive tests for banned substances.
A Potential Shift in Team practices
For years, teams routinely reviewed a rider’s ABP data before offering contracts. This practice served as a due diligence measure, helping to mitigate the risk of signing an athlete with a questionable history.
However, a recent report suggests a concerning trend. According to a source speaking with Velo, many teams are now foregoing this crucial step.
Here’s what’s happening:
* Riders must now explicitly consent to allow teams access to their ABP data.
* This consent is reportedly being granted less frequently.
* Major rider contracts, worth millions of dollars, are being finalized without teams reviewing the athlete’s biological passport.
This raises critical questions: are teams losing faith in the ABP’s relevance? Or is there a growing, and potentially hazardous, assumption that the professional peloton is cleaner than it once was?
What Does This Mean for the Future of anti-Doping?
The outcome of the Lascano case will be closely watched by the cycling community. It will likely influence the UCI’s continued commitment to utilizing the ABP – one of cycling’s most effective, yet controversial, anti-doping tools.
You, as a fan of the sport, should be aware of these developments.The integrity of professional cycling depends on robust anti-doping measures and a willingness to confront potential violations.
The current trend of teams potentially pulling back from reviewing ABP data is a cause for concern. It underscores the need for continued vigilance and a commitment to ensuring a fair and clean sport for all.